Brought to you by 
Ethypharm, Viatris further develop tramadol
26 Jul 2002
Executive Summary
Ethypharm (drug delivery) will team up with Viatris (formerly part of Degussa's Asta Medica group, which has just spun it off in a leveraged buy-out) to develop and market a Flashtab oral formulation of tramadol, an analgesic for moderate to severe pain that acts as an opioid agonist to inhibit monoamine reuptake.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ethypharm, Viatris further develop tramadol
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice